{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:20:34Z","timestamp":1773271234565,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10067-026-08002-4","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T08:02:10Z","timestamp":1771833730000},"page":"2329-2337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the relationship between XDH gene variants and serum urate and xanthine dehydrogenase levels in gout"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4149-7204","authenticated-orcid":false,"given":"Juan Alan","family":"Rom\u00e1n-Olmos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1751-3454","authenticated-orcid":false,"given":"Yessica","family":"Zamudio-Cuevas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0675-0227","authenticated-orcid":false,"given":"Karina","family":"Mart\u00ednez-Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3923-6956","authenticated-orcid":false,"given":"Rolando","family":"Espinosa-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-2862","authenticated-orcid":false,"given":"Javier","family":"Fern\u00e1ndez-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"8002_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4081\/reumatismo.2011.238","volume":"63","author":"W Grassi","year":"2012","unstructured":"Grassi W, De Angelis R (2012) Clinical features of gout. Reumatismo 63:238\u2013245. https:\/\/doi.org\/10.4081\/reumatismo.2011.238","journal-title":"Reumatismo"},{"issue":"1","key":"8002_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4078\/jrd.2024.0054","volume":"32","author":"EY Ahn","year":"2025","unstructured":"Ahn EY, So MW (2025) The pathogenesis of gout. J Rheum Dis 32(1):8\u201316. https:\/\/doi.org\/10.4078\/jrd.2024.0054","journal-title":"J Rheum Dis"},{"issue":"10287","key":"8002_CR3","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, Abhishek A (2021) Gout. Lancet 397(10287):1843\u20131855. https:\/\/doi.org\/10.1016\/S0140-6736(21)00569-9","journal-title":"Lancet"},{"key":"8002_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-013-0400-9","volume":"16","author":"MA Martillo","year":"2014","unstructured":"Martillo MA, Nazzal L, Crittenden DB (2014) The crystallization of monosodium urate. Curr Rheumatol Rep 16:400. https:\/\/doi.org\/10.1007\/s11926-013-0400-9","journal-title":"Curr Rheumatol Rep"},{"key":"8002_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2741\/3950","volume":"17","author":"M Jin","year":"2012","unstructured":"Jin M, Yang F, Yang I, Yin Y, Luo JJ, Wang H, Yang XF (2012) Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed) 17:656\u2013669. https:\/\/doi.org\/10.2741\/3950","journal-title":"Front Biosci (Landmark Ed)"},{"key":"8002_CR6","doi-asserted-by":"publisher","first-page":"1515176","DOI":"10.3389\/fendo.2025.1515176","volume":"16","author":"J Zhang","year":"2025","unstructured":"Zhang J, Sun N, Zhang W, Yue W, Qu X, Li Z, Xu G (2025) The impact of uric acid on musculoskeletal diseases: clinical associations and underlying mechanisms. Front Endocrinol (Lausanne) 16:1515176. https:\/\/doi.org\/10.3389\/fendo.2025.1515176","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7081","key":"8002_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, P\u00e9trilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440(7081):237\u2013241. https:\/\/doi.org\/10.1038\/nature04516","journal-title":"Nature"},{"key":"8002_CR8","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1073\/pnas.1012743108","volume":"108","author":"AE Denoble","year":"2011","unstructured":"Denoble AE, Huffman KM, Stabler TV, Kelly SJ, Hershfield MS, McDaniel GE, Coleman RE, Kraus VB (2011) Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc Natl Acad Sci U S A 108:2088\u20132093. https:\/\/doi.org\/10.1073\/pnas.1012743108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8002_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biochi.2015.06.025","volume":"116","author":"WG Lima","year":"2015","unstructured":"Lima WG, Martins-Santos ME, Chaves VE (2015) Uric acid as a modulator of glucose and lipid metabolism. Biochimie 116:17\u201323. https:\/\/doi.org\/10.1016\/j.biochi.2015.06.025","journal-title":"Biochimie"},{"key":"8002_CR10","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/s0891-5849(02)00956-5","volume":"33","author":"R Harrison","year":"2002","unstructured":"Harrison R (2002) Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med 33:774\u2013797. https:\/\/doi.org\/10.1016\/s0891-5849(02)00956-5","journal-title":"Free Radic Biol Med"},{"key":"8002_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101882","volume":"41","author":"M Bortolotti","year":"2021","unstructured":"Bortolotti M, Polito L, Battelli MG, Bolognesi A (2021) Xanthine oxidoreductase: one enzyme for multiple physiological tasks. Redox Biol 41:101882. https:\/\/doi.org\/10.1016\/j.redox.2021.101882","journal-title":"Redox Biol"},{"key":"8002_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.101072","volume":"21","author":"HM Schmidt","year":"2019","unstructured":"Schmidt HM, Kelley EE, Straub AC (2019) The impact of xanthine oxidase (XO) on hemolytic diseases. Redox Biol 21:101072. https:\/\/doi.org\/10.1016\/j.redox.2018.101072","journal-title":"Redox Biol"},{"issue":"Pt 3","key":"8002_CR13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1113\/jphysiol.2003.055913","volume":"555","author":"CE Berry","year":"2004","unstructured":"Berry CE, Hare JM (2004) Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555(Pt 3):589\u2013606. https:\/\/doi.org\/10.1113\/jphysiol.2003.055913","journal-title":"J Physiol"},{"key":"8002_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12931-023-02481-8","volume":"24","author":"L Gao","year":"2023","unstructured":"Gao L, Rafaels N, Dudenkov TM, Damarla M, Damico R, Maloney JP et al (2023) Xanthine oxidoreductase gene polymorphisms are associated with high risk of sepsis and organ failure. Respir Res 24:177. https:\/\/doi.org\/10.1186\/s12931-023-02481-8","journal-title":"Respir Res"},{"key":"8002_CR15","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.46399.2","volume":"10","author":"JM Vargas-Morales","year":"2021","unstructured":"Vargas-Morales JM, Guevara-Cruz M, Aradillas-Garc\u00eda C, Noriega LG, Tovar A, Alegr\u00eda-Torres JA (2021) Polymorphisms of the genes ABCG2, SLC22A12 and XDH and their relation with hyperuricemia and hypercholesterolemia in Mexican young adults. F1000Res 10:217. https:\/\/doi.org\/10.12688\/f1000research.46399.2","journal-title":"F1000Res"},{"key":"8002_CR16","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3390\/jcm8050738","volume":"8","author":"JH Lee","year":"2019","unstructured":"Lee JH, Go TH, Lee SH, Kim J, Huh JH, Kim JY et al (2019) Association between serum urate and risk of hypertension in menopausal women with XDH gene. J Clin Med 8:738. https:\/\/doi.org\/10.3390\/jcm8050738","journal-title":"J Clin Med"},{"key":"8002_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/FPC.0b013e3282f55e2e","volume":"18","author":"M Kudo","year":"2008","unstructured":"Kudo M, Moteki T, Sasaki T, Konno Y, Ujiie S, Onose A, Mizugaki M, Ishikawa M, Hiratsuka M (2008) Functional characterization of human xanthine oxidase allelic variants. Pharmacogenet Genomics 18:243\u2013251. https:\/\/doi.org\/10.1097\/FPC.0b013e3282f55e2e","journal-title":"Pharmacogenet Genomics"},{"issue":"12","key":"8002_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13121439","volume":"13","author":"G Massimo","year":"2024","unstructured":"Massimo G, Dyson N, Olotu F, Khambata RS, Ahluwalia A (2024) Potential opportunities for pharmacogenetic-based therapeutic exploitation of xanthine dehydrogenase in cardiovascular disease. Antioxidants 13(12):1439. https:\/\/doi.org\/10.3390\/antiox13121439","journal-title":"Antioxidants"},{"key":"8002_CR19","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D et al (2015) 2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 74:1789\u20131798. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208237","journal-title":"Ann Rheum Dis"},{"key":"8002_CR20","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","volume":"22","author":"X Sol\u00e9","year":"2006","unstructured":"Sol\u00e9 X, Guin\u00f3 E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22:1928\u20131929. https:\/\/doi.org\/10.1093\/bioinformatics\/btl268","journal-title":"Bioinformatics"},{"issue":"21","key":"8002_CR21","doi-asserted-by":"publisher","first-page":"7931","DOI":"10.1073\/pnas.0400973101","volume":"101","author":"K Okamoto","year":"2004","unstructured":"Okamoto K, Matsumoto K, Hille R, Eger BT, Pai EF, Nishino T (2004) The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition. Proc Natl Acad Sci U S A 101(21):7931\u20137936. https:\/\/doi.org\/10.1073\/pnas.0400973101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8002_CR22","doi-asserted-by":"publisher","first-page":"3527579","DOI":"10.1155\/2016\/3527579","volume":"2016","author":"MG Battelli","year":"2016","unstructured":"Battelli MG, Polito L, Bortolotti M, Bolognesi A (2016) Xanthine oxidoreductase-derived reactive species: physiological and pathological effects. Oxid Med Cell Longev 2016:3527579. https:\/\/doi.org\/10.1155\/2016\/3527579","journal-title":"Oxid Med Cell Longev"},{"key":"8002_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1758-5996-4-12","volume":"4","author":"EP de Oliveira","year":"2012","unstructured":"de Oliveira EP, Burini RC (2012) High plasma uric acid concentration: causes and consequences. Diabetol Metab Syndr 4:12. https:\/\/doi.org\/10.1186\/1758-5996-4-12","journal-title":"Diabetol Metab Syndr"},{"issue":"35","key":"8002_CR24","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.2174\/0929867323666160725091915","volume":"23","author":"MG Battelli","year":"2016","unstructured":"Battelli MG, Polito L, Bortolotti M, Bolognesi A (2016) Xanthine oxidoreductase in drug metabolism: beyond a role as a detoxifying enzyme. Curr Med Chem 23(35):4027\u20134036. https:\/\/doi.org\/10.2174\/0929867323666160725091915","journal-title":"Curr Med Chem"},{"key":"8002_CR25","doi-asserted-by":"publisher","first-page":"1759720X2513663","DOI":"10.1177\/1759720X251366360","volume":"17","author":"TR Merriman","year":"2025","unstructured":"Merriman TR, Rosas-Chavez F, Stamp LK (2025) The genetics of gout: translation into clinical practice. Ther Adv Musculoskelet Dis 17:1759720X251366360. https:\/\/doi.org\/10.1177\/1759720X251366360","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"8002_CR26","doi-asserted-by":"publisher","first-page":"102864","DOI":"10.1016\/j.redox.2023.102864","volume":"67","author":"G Massimo","year":"2023","unstructured":"Massimo G, Khambata RS, Chapman T, Birchall K, Raimondi C, Shabbir A, Dyson N, Rathod KS, Borghi C, Ahluwalia A (2023) Natural mutations of human XDH promote the nitrite (NO2-)-reductase capacity of xanthine oxidoreductase: a novel mechanism to promote redox health? Redox Biol 67:102864. https:\/\/doi.org\/10.1016\/j.redox.2023.102864","journal-title":"Redox Biol"},{"key":"8002_CR27","doi-asserted-by":"publisher","first-page":"1662037","DOI":"10.3389\/fendo.2025.1662037","volume":"16","author":"KL Nelson","year":"2026","unstructured":"Nelson KL, Voruganti VS (2026) Implication of xanthine oxidoreductase in oxidative stress-related chronic diseases. Front Endocrinol (Lausanne) 16:1662037. https:\/\/doi.org\/10.3389\/fendo.2025.1662037","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"8002_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51724-1","volume":"14","author":"J Kim","year":"2024","unstructured":"Kim J, Lee SY, Lee J, Yoon S, Kim EG, Lee E, Kim N, Lee S, Gym H, Park SI (2024) Effects of uric acid on ischemic diseases, stratified by lipid levels: a drug-target, nonlinear Mendelian randomization study. Sci Rep 14(1):1338. https:\/\/doi.org\/10.1038\/s41598-024-51724-1","journal-title":"Sci Rep"},{"issue":"11","key":"8002_CR29","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/s41440-021-00724-z","volume":"44","author":"T Tsuchihashi","year":"2021","unstructured":"Tsuchihashi T (2021) Which is more important, xanthine oxidase activity or uric acid itself, in the risk for cardiovascular disease? Hypertens Res 44(11):1543\u20131545. https:\/\/doi.org\/10.1038\/s41440-021-00724-z","journal-title":"Hypertens Res"},{"issue":"4","key":"8002_CR30","doi-asserted-by":"publisher","first-page":"5685","DOI":"10.3892\/mmr.2015.4135","volume":"12","author":"B Wu","year":"2015","unstructured":"Wu B, Hao Y, Shi J, Geng N, Li T, Chen Y, Sun Z, Zheng L, Li H, Li N, Zhang X, Sun Y (2015) Association between xanthine dehydrogenase tag single nucleotide polymorphisms and essential hypertension. Mol Med Rep 12(4):5685\u20135690. https:\/\/doi.org\/10.3892\/mmr.2015.4135","journal-title":"Mol Med Rep"},{"issue":"1","key":"8002_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/art.39799","volume":"69","author":"N Dalbeth","year":"2017","unstructured":"Dalbeth N, Choi HK, Terkeltaub R (2017) Review: gout: a roadmap to approaches for improving global outcomes. Arthritis Rheumatol 69(1):22\u201334. https:\/\/doi.org\/10.1002\/art.39799","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"8002_CR32","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrrheum.2012.144","volume":"8","author":"AM Reginato","year":"2012","unstructured":"Reginato AM, Mount DB, Yang I, Choi HK (2012) The genetics of hyperuricaemia and gout. Nat Rev Rheumatol 8(10):610\u2013621. https:\/\/doi.org\/10.1038\/nrrheum.2012.144","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"8002_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01916-y","volume":"9","author":"L Du","year":"2024","unstructured":"Du L, Zong Y, Li H, Wang Q, Xie L, Yang B, Pang Y, Zhang C, Zhong Z, Gao J (2024) Hyperuricemia and its related diseases: mechanisms and advances in therapy. Signal Transduct Target Ther 9(1):212. https:\/\/doi.org\/10.1038\/s41392-024-01916-y","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"8002_CR34","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1046\/j.1523-1755.2000.00082.x","volume":"57","author":"D Levartovsky","year":"2000","unstructured":"Levartovsky D, Lagziel A, Sperling O, Liberman U, Yaron M, Hosoya T, Ichida K, Peretz H (2000) XDH gene mutation is the underlying cause of classical xanthinuria: a second report. Kidney Int 57(6):2215\u20132220. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00082.x","journal-title":"Kidney Int"},{"issue":"23","key":"8002_CR35","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.2174\/1381612823666170417130115","volume":"23","author":"M Schuchardt","year":"2017","unstructured":"Schuchardt M, Herrmann J, Tolle M, van der Giet M (2017) Xanthine oxidase and its role as target in cardiovascular disease: cardiovascular protection by enzyme inhibition? Curr Pharm Des 23(23):3391\u20133404. https:\/\/doi.org\/10.2174\/1381612823666170417130115","journal-title":"Curr Pharm Des"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08002-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08002-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08002-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T08:21:33Z","timestamp":1773217293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08002-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["8002"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08002-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}